Comprehensive Professional Practice Test — Drug Information
Resources, Literature Evaluation, Adverse Drug Reactions,
Medication Safety, Regulatory Affairs & Pharmacoeconomics — 190
Multiple-Choice Questions with Answers & Detailed Rationales
SECTION 1: DRUG INFORMATION RESOURCES AND LITERATURE EVALUATION (Questions 1-
38)
Question 1
A drug information specialist receives a call from a physician asking about the mechanism of
action of a newly approved monoclonal antibody. Which type of tertiary resource would
provide the most comprehensive and current information?
A. Package insert
B. Systematic review
C. Drug Facts and Comparisons
D. Primary literature article
Correct Answer: C
Explanation: Drug Facts and Comparisons is a tertiary resource that compiles comprehensive
drug monographs including mechanism of action for approved medications.
Question 2
,When evaluating a clinical trial for potential bias, a drug information specialist notices that
neither the participants nor the investigators knew which treatment group participants were
assigned to. This study design element is best described as:
A. Single blinding
B. Double blinding
C. Open-label design
D. Crossover design
Correct Answer: B
Explanation: Double blinding means both participants and investigators are unaware of
treatment assignments, reducing detection and performance bias.
Question 3
A pharmacist needs to determine the bioequivalence of a generic formulation compared to
its brand-name counterpart. Which parameter is most critical to evaluate?
A. Dissolution rate
B. Maximum plasma concentration (Cmax)
C. Area under the curve (AUC)
D. Time to maximum concentration (Tmax)
Correct Answer: C
Explanation: AUC represents total drug exposure and is the primary pharmacokinetic
parameter for establishing bioequivalence between formulations.
,Question 4
Which of the following best describes the purpose of a meta-analysis in drug information
practice?
A. To generate new primary data from clinical trials
B. To systematically combine results from multiple studies to derive pooled estimates
C. To provide expert opinion on controversial therapeutic issues
D. To describe individual patient case outcomes
Correct Answer: B
Explanation: Meta-analysis statistically combines results from multiple studies, increasing
statistical power and providing pooled effect estimates.
Question 5
A drug information specialist is asked to evaluate a study examining the association between
a rare adverse event and a newly marketed medication. Which study design would be most
appropriate for investigating this relationship?
A. Randomized controlled trial
B. Case-control study
C. Cross-sectional study
D. Phase I clinical trial
Correct Answer: B
, Explanation: Case-control studies are efficient for studying rare outcomes by retrospectively
comparing affected cases with unaffected controls.
Question 6
When assessing the internal validity of a randomized controlled trial, which factor is most
important to evaluate?
A. Sample size calculation
B. Randomization and allocation concealment methods
C. Geographic location of study sites
D. Number of authors on the publication
Correct Answer: B
Explanation: Proper randomization and allocation concealment prevent selection bias and
are fundamental to internal validity in RCTs.
Question 7
A drug information specialist receives a question about the off-label use of a medication.
Which resource would be most appropriate to consult first?
A. FDA-approved package insert
B. Micromedex
C. The Cochrane Library
D. United States Pharmacopeia
Correct Answer: B